Viruses 2013, 5, 1143-1152; doi:10.3390/v5041143
Induced Degradation of Tat by Nucleocapsid (NC) via the
Proteasome Pathway and Its Effect on HIV Transcription
Hye-Won Hong 1, Seong-Wook Lee 2 and Heejoon Myung 1,*
1 Department of Bioscience and Biotechnology, Hankuk University of Foreign Studies, Yong-In,
Gyung-Gi Do 449-791, Korea; E-Mail: email@example.com
2 Department of Molecular Biology, Institute of Nanosensor and Biotechnology,
Dankook University, Yong-In, Gyung-Gi Do 448-701, Korea; E-Mail: firstname.lastname@example.org
* Author to whom correspondence should be addressed; E-Mail: email@example.com;
Tel.: +82-31-330-4098; Fax: +82-31-330-4566.
Received: 18 March 2013; in revised form: 16 April 2013 / Accepted: 16 April 2013 /
Published: 23 April 2013
Abstract: Human Immunodeficiency Virus type 1 (HIV-1) is a retrovirus that causes
acquired immunodeficiency syndrome (AIDS). HIV-1 Tat protein upregulates
transcriptional transactivation. The nucleocapsid protein NC of HIV-1 is a component of
virion and plays a key role in genome packaging. Herein, we have demonstrated the
interaction between NC and Tat by means of a yeast two-hybrid assay, GST pull-down
analysis, co-immunoprecipitation and subcellular colocalization analysis. We observed that
the level of Tat was significantly reduced in the presence of NC. But NC did not affect
mRNA expression level of Tat. The level of Tat in the presence of NC was increased by
treating cells with a proteasome inhibitor, MG132. The ubiquitination state of Tat was not
seen to increase in the presence of NC, suggesting the proteasomal degradation was
independent of ubiquitination. Lowered level of Tat in the presence of NC led to a decrease
in Tat-mediated transcriptional transactivation.
Keywords: human immunodeficiency virus (HIV); nucleocapsid (NC); Tat; proteasomal
Viruses 2013, 5
It is estimated that there are 39 million AIDS patients worldwide. After 8–10 years of asymptomatic
period, HIV causes devastation of the immune system leading to immunodeficiency. The virus infects
immune cells including CD4+ T cells, dendritic cells and macrophages .
HIV Tat is a small nuclear protein encoded by an RNA consisting of two exons produced from
multiple splicing . It binds to the transcription activator response (TAR) element located at the 5'
end of the viral RNA transcript and enhances transcription activity . TAR RNA possesses a
secondary structure consisting of a stem, bulge and loop, of which the bulge is the site where Tat binds .
It recruits human cyclinT1-Cdk 9 complex which is the component of a positive transcription
elongation factor b (P-TEFb), to the loop . Cdk 9 induces hyperphosphorylation of RNA
polymerase II, resulting in enhanced transcription elongation. Tat also recruits p300/CBP and PCAF
which are transcriptional coactivators/acetyltransferases to the promoter [4–6]. P-TEFb is then readily
recruited to the promoter by acetylated Tat.
Nucleocapsid (NC) is a 55 amino-acid basic protein produced from the processing of Gag
precursor. It is a zinc finger protein containing two copies of CCHC motifs that is conserved among
retroviruses . This domain binds to the packaging signal (psi) at 5' LTR of the viral genomic RNA
for encapsidation [8–10]. It possesses a nucleic acid chaperone activity which is crucial for the
annealing of tRNA3Lys and plus strand transfer . It also plays a role in minus strand transfer by
destabilization of TAR and the pausing of reverse transcription . Another activity of NC is the
induction of dimerization of viral genomic RNA in the virion core . Virion NC was also shown to
migrate from cytoplasm to nucleus and to control early viral mRNA . Thus NC plays multiple
roles in virus life cycle.
The 55 KDa Gag precursor protein expressed from unspliced viral mRNA is transported to plasma
membrane. After budding, Gag is cleaved by viral protease to produce p17 matrix, p24 capsid, p7
nucleocapsid, and p6 .
Herein is reported an additional role of NC based on the novel observation that NC and Tat
interacted with each other. We hypothesize that NC from prematurely processed Gag may control
transcriptional activation by Tat at a late stage of viral infection.
2. Results and Discussion
Plasmid expressing NC and plasmid expressing Tat were cotransformed to yeast strain AH109 and
the interaction of the two proteins were observed (Figure 1A). To confirm specific interaction between
NC and Tat, HIV-1 Vpu protein was used as a negative control. Yeast cell cotransformed with NC and
Vpu didn’t grow in SD media D.O. tryptophan, leucine, and histidine. Next, in vitro pulldown assay
was performed. Purified recombinant GST-fused NC or GST alone was mixed with cell lysates of
BHK-21 expressing Tat. The binding of Tat to GST-fused NC, not to GST, was observed (Figure 1B).
GST pulldown of Tat was visualized by western blot. Coimmunoprecipitation was also used for
observing the interaction between the two proteins. From the cell lysate expressing NC and Tat, the
two proteins were immunoprecipitated together (Figure 1C). But, NC and Vpu proteins were not
observed to interact with each other. Subcellular colocalization of the two proteins was also confirmed
Viruses 2013, 5
under laser scanning confocal microscope. It has been reported that virion NC localizes to the nucleus
at the early infection stage . In our experiments, NC was predominantly observed in the cytoplasm
in the absence of Tat. It seemed that only part of overexpressed NC translocated to nucleus in the
absence of Tat. However, in the presence of Tat, NC was shown to translocate to the nucleus and
colocalize with Tat (Figure 1D). Both NC and Tat are translated in the cytoplasm and the binding
between the two proteins seems to recruit NC to nucleus with their specific interaction. Tat has a nuclear
localization signal (NLS) in the basic domain and mainly localizes in the nucleus, inducing transcription
activation. The binding between the two proteins resulted in translocation of NC to the nucleus.
Figure 1. Interaction between HIV nucleocapsid (NC) protein and Tat (A) Plasmid
expressing NC and plasmid expressing Tat were transformed to AH109 and the yeast was
grown on media lacking histidine. Murine p53 and SV40 large T antigens were used as a
positive control. HIV Vpu was used as a negative control. The lower panel shows yeast
colonies resulting from interaction of the two proteins. Plasmids pGBK-NC, pGAD-Tat
and pGAD-Vpu were constructed and utilized. pGBKT7-53 (murine p53) and pGADT7-T
(SV40 large T antigen) were used as positive controls. Yeast strain AH109, transformed
only with pGAD-Tat or pGAD-Vpu were used as negative controls; (B) Purified
recombinant GST-fused NC was used to pulldown BKH21 cell lysate expressing Tat. GST
was used as the negative control (third lane). pcDNA/V5-Tat was transfected to BHK-21
cells. After 24 h, a RIPA lysis buffer was added and lysis was performed at 4 °C for
30 min. The pellet was discarded after centrifugation and the lysate was obtained. GST or
GST-NC and 30 μL of glutathione sepharose 4B bead was added to the lysate and the
mixture was incubated at 4 °C overnight. HNGT buffer was used for washing and bound
proteins were eluted after boiling with a 4XSDS sample buffer; (C) Flag-tagged NC and
V5-tagged Tat or V5-tagged Vpu were expressed in HEK293 cells. The lysate was
subjected to an immunoprecipitation with the anti-Flag antibody and detected with the
anti-V5 antibody in a western blot analysis. The anti-IgG antibody was used a as the
negative control; (D) Flag-tagged NC (green) and V5-tagged Tat (red) were expressed in
HEK293 cells and observed under a confocal laser scanning microscope. At least three
experiments were performed with essentially the same results.
Viruses 2013, 5
Figure 1. Cont.
The outcome of interaction between the two proteins was explored. When the two proteins were
co-expressed in HEK293 cells, the amount of Tat was observed to decrease through a western blot
analysis (Figure 2A). Co-expression of GST did not alter the amount of Tat. To determine whether this
change resulted from transcriptional control, we examined the amount of mRNA expressing Tat by
reverse transcription PCR analysis. The amount of mRNA expressing Tat did not change in the
presence or in the absence of NC (Figure 2B). Accordingly, Tat was hypothesized to degrade
posttranslationally in the presence of NC. The primary degradation mechanism of proteins in
eukaryotic cells involves the ubiquitin-proteasome pathway. Ubiquitin binds to unnecessary or
misfolded proteins and this modification is recognized by the 26s proteasome leading to degradation of
the target proteins . To confirm whether the decrease of Tat in the presence of NC was via
proteasomal degradation, MG132, a proteasome inhibitor, was used. The amount of Tat was seen to
decrease less in the presence of NC when the cells were treated with MG132 (lanes 2 and 5, Figure 2C). As
a comparison, the amount of Tat did not decrease in the presence of HCV core (lanes 3 and 6). The
proteasome constitutively degrades nearly all proteins, so treatment with MG-132 is expected to
increase the amount of Tat in the cell, appearing as if there was an increase in Tat expression.
However, this is actually a decrease in Tat degradation. There is a decrease in Tat level with NC, but
not alone or with HCV core protein, in untreated cells. This difference is alleviated when the
proteasome is shut down, thus the proteasome is most likely causing the induced degradation of Tat by
NC. To see whether ubiquitination occurred before the proteasomal degradation of Tat, ubiquitination
assay was performed. In the presence of NC, the ubiquitination of Tat did not increase (Figure 2D).
Hdm2, a proto-oncoprotein, is already known to induce the ubiquitination of Tat  and this was
therefore used as the positive control in this experiment.
Since Tat binds to the TAR RNA element and activates transcription elongation , we checked
whether the degradation of Tat by NC affected this process. A reporter plasmid containing the
luciferase gene under the control of HIV-1 LTR promoter was used. As negative controls, HIV p24, or
GST was used instead of NC. In the presence of Tat, reporter activity increased notably (Figure 3A). In
the presence of NC, reporter activity decreased 22% when compared to the tests in the presence of
Viruses 2013, 5
HIV p24 or GST. The decreased reporter activity by NC was effectively rescued by treatment with
MG132 (Figure 3B). Thus, we have confirmed that the NC-mediated degradation of Tat results in the
decrease of transcriptional activation.
Figure 2. NC induced proteasomal degradation of Tat in an ubiquitin-independent pathway
(A) V5-tagged Tat and Flag-tagged NC or GST were expressed in HEK293 cells and
detected by a western blot analysis. Tat decreased in the presence of NC (middle lane),
while GST had no effect; (B) Real time RT-PCR was performed to observe any change in
the mRNA level of Tat in the presence or in the absence of NC. HCV core and HIV rev
were used as the negative control; (C) V5-tagged Tat was expressed with Flag-tagged NC
or HA-tagged HCV core in HEK293 cells. The decrease of Tat in the presence of NC was
reversed when MG132, a proteasome inhibitor, was added to the culture (fifth lane); (D)
HEK293 cells expressing His-tagged Ub, Flag-tagged NC, and HA-tagged Tat were grown
in the presence of MG132 for 5 h at which time the lysate was passed through Ni-NTA
agarose column. Western blot was performed with the anti-HA antibody. Hdm2 was used as
a positive control. At least three experiments were performed with essentially the same results.
Viruses 2013, 5
Figure 3. NC inhibited transactivation of Tat. (A) A luciferase reporter plasmid under the
control of the HIV-1 LTR promoter was expressed with Tat in the presence of HIV NC,
GST, or HIV p24; (B) Luciferase reporter activity was measured after treatment of cells
with MG132. The mean value of three independent experiments is shown. Transcription
efficiency was normalized with MUG assay.
There has been a report that HIV Tat is degraded by cellular p14ARF in an ubiquitin-independent
pathway . In the latter study the degradation resulted in a decrease of transactivation. Many other
investigations have reported that proteasomal degradation occurs independently of ubiquitination .
For example, tumor suppressor p53 is degraded by both the ubiquitin-dependent and ubiquitin-
independent pathways . There is also a report of viral transactivator degradation by its own viral
protein. The hepatitis B virus transactivator X protein is degraded by both ubiquitin-dependent and
ubiquitin-independent pathways . Proteasomal degradation of HBV X protein induced by HBV
core was suggested as a new mechanism of controlling virus life cycle .
Tat upregulates transcription from proviral genome. Transcribed early genes include Tat, Rev, and
Nef. Late genes include Gag, Pol, Env, Vpr, Vpu, and Vif which are expressed in a Rev-dependent
manner [22,23]. Although cleaved NC is generally found after proteolytic processing of Gag in
released viral particles, premature processing of HIV Gag in cytoplasm is also reported . A similar
premature cytoplasmic processing of Gag was also shown in an avian retrovirus . When NC is
accumulated after premature processing in cytoplasm, it would have a chance to interact with Tat
which was abundantly expressed at the early stage of infection. This interaction can lead to
degradation of Tat via proteasomal pathway, leading to decrease in transcription at late stage of viral
infection cycle. The 22% decrease of Tat-mediated transcription in the presence of NC in our
experiment cannot be responsible for the entire silencing of transcription at the late stage. Since both
NC and Tat were overexpressed in our experiment, Tat degradation effect would not be fully reflected.
And there could be other mechanisms yet to be elucidated responsible for this transcriptional control.
Nonetheless, the virus needs to minimize unnecessary transcription from the viral genome.
Based on our findings, we suggest an additional role of NC related to transcriptional control at the
late stage of HIV replication.
Viruses 2013, 5
3.1. Reporter Assay
For the transcription activity tests, BHK21 or HEK293 cells were used. Plasmids pcDNA/luc-LTR
(0.5 μg), pBud-Tat/NC (2 μg), pBud-Tat/p24 (2 μg), pBud-Tat/GST (2 μg), and pCH110 (0.5 μg,
Amersham Biosciences) were mixed with 8 μg of Lipofectamin 2000 (Invitrogen) and cells were
incubated. After 19 h, MG132 (Calbiochem) was added at 10 μM to the mixture and incubated for 5 h.
Luciferase assay mixture (Promega) was added and the activity was measured in a luminometer
3.2. Proteasomal Degradation Assay
Cells were seeded in a 60 mm plate at 2 × 105 cells and incubated for 18 h. Then 2 μg of
pcDNA/V5-Tat, 0.5 μg of pCMV/Flag-NC and 0.5 μg of pcDNA-GST (or pcDNA-HA-core) were
transfected to the cells using Lipofectamin 2000. After 18 h of incubation, 10 μM of MG132
(Calbiochem) was added to the mixture and incubated for a further 6 h.
3.3. Yeast Two Hybrid Assay
The Matchmaker two-hybrid system 3 (Clontech) was used. Plasmids pGBK-NC, pGAD-Tat and
pGAD-Vpu were constructed and utilized according to the manufacturer’s protocol. pGBKT7-53
(murine p53) and pGADT7-T (SV40 large T antigen) were used as positive controls. Yeast strain
AH109, trasformed only with pGAD-Tat or pGAD-Vpu were used as negative controls.
3.4. GST Pulldown
To obtain NC fused to GST, 1 liter of E. coli harboring pGNC1 was cultured and induced with
1 mM IPTG for 3 h. The protein was purified using affinity chromatography.
For GST pulldown analysis, 10 μg of pcDNA/V5-Tat was transfected to 5 × 105 BHK-21 cells.
After 24 h, a RIPA lysis buffer (50 mM Tris-Cl, pH 8.0, 1% NP-40, 0.5% sodium deoxycholate, and
150 mM NaCl) was added and lysis was performed at 4 °C for 30 min. The pellet was discarded after
centrifugation and the lysate was obtained. Exactly 4 μg each of GST and GST-NC and 30 μL of
glutathione sepharose 4B bead (Amersham Biosciences) were added to the lysate and the mixture was
incubated at 4 °C overnight. Exactly 1 mL of HNGT buffer was used for washing and bound proteins
were eluted after boiling with a 4×SDS sample buffer.
Exactly 8 μg of pcDNA/V5-Tat or pcDNA/V5-Vpu and 2 μg of pCMV/Flag-NC were used for
transfection of HEK293 cells. Cells were lysed with a RIPA buffer in 24 h and anti-Flag antibody was
added and further incubated at 4 °C overnight. Exactly 20 μL of protein G (Sigma-Aldrich) was added
and the mixture was washed with lysis buffer 3 times.
Viruses 2013, 5
3.6. Subcellular Colocalization Analysis
Plasmids pcDNA/V5-Tat and pCMV/Flag-NC were used to transfect HEK293 cells. Cells were
fixed and rabbit polyclonal anti-Flag antibody was added and incubated for 1 h. After washing 3 times,
FITC-conjugated secondary antibody was added and the mixture was then incubated for 1 h. After
washing 3 times, 1:200 diluted mouse monoclonal anti-V5 antibody was added. After 3 times of
washing, TRITC-conjugated secondary antibody was incubated and the mixture was mounted on a
glass plate and observed under a confocal scanning laser microscope (Zeiss).
3.7. Realtime RT PCR
Plasmids pcDNA/V5-Tat and pCMV/Flag-NC or pcDNA/HA-Core, pcDNA/HA-Rev were used for
transfection of HEK293 cells. Cells were harvested after 24 h and total RNA was isolated using an
RNA kit (Macherey-Nagel). Reverse transcription was performed using M-MLV reverse transcriptase
(United States Biological) with the primer 5'-CTATTCCTTCGGGCCTGT-3'. Real-time PCR was
performed with iQ SYBR Green supermix (Bio-Rad) for Tat and GAPDH gene expression. The real-time
detection system was used to monitor the SYBR green signal at the end of each expression period for
40 cycles. Tat RNA levels were calculated by the delta/delta CT method with GAPDH genes.
3.8. Ubiquitination Assay
Exactly 7 μg of pcDNA/HA-Tat, 2 μg of pCMV/Flag-NC and 5 μg of His-ubiquitin were used for
the transient transfection of HEK293 cells. 40 hours after transfection, MG132 was added at 10 mM
and the mixture was incubated for 5 h. Cells were then lysed with 1×RIPA buffer and subjected to
sonication for 5 min. Supernatant was collected after centrifugation and loaded on Ni-NTA resin
(Qiagen). After 5 h of binding reaction, the column was washed with 1×RIPA buffer 3 times and the
eluate was analysed on an SDS-PAGE.
We showed the interaction between NC and Tat. The interaction induced nuclear translocation of
NC and degradation of Tat via proteasomal pathway. Accumulation of prematurely processed NC in
the cytoplasm can lead to decrease of Tat-mediated transcription.
We would like to thank Steven R. Grossman for providing the pCMV-mdm2, Ji Chang You for
pCMV/Flag-NC and pGNC1 plasmids, and Yonghoon Kee for plasmid expressing Ubiquitin. This
work was supported by 2008 National Research Foundation of Korea Grant (C00195) funded by the
Korean Government and 2012 GRRC.
Conflict of Interest
The authors declare no conflict of interest.
Viruses 2013, 5
References and Notes
1. Kim, S.Y.; Byrn, R.; Groopman, J.; Baltimore, D. Temporal aspects of DNA and RNA synthesis
during human immunodeficiency virus infection: Evidence for differential gene expression.
J. Virol. 1989, 63, 3708–3713.
2. Marcello, A.; Zoppe, M.; Giacca, M. Multiple modes of transcriptional regulation by the HIV-1
Tat transactivator. IUBMB Life 2001, 51, 175–181.
3. Raha, T.; Cheng, S.W.; Green, M.R. HIV-1 Tat stimulates transcription complex assembly
through recruitment of TBP in the absence of TAFs. PLoS Biol. 2005, 3, e44.
4. Hottiger, M.O.; Nabel, G.J. Interaction of human immunodeficiency virus type 1 Tat with the
transcriptional coactivators p300 and CREB binding protein. J. Virol. 1998, 72, 8252–8256.
5. Marzio, G.; Tyagi, M.; Gutierrez, M.I.; Giacca, M. HIV-1 tat transactivator recruits p300 and
CREB-binding protein histone acetyltransferases to the viral promoter. Proc. Natl. Acad. Sci. USA
1998, 95, 13519–13524.
6. Ping, Y.H.; Rana, T.M. Tat-associated kinase (P-TEFb): A component of transcription
preinitiation and elongation complexes. J. Biol. Chem. 1999, 274, 7399–7404.
7. Covey, S.N. Amino acid sequence homology in gag region of reverse transcribing elements and
the coat protein gene of cauliflower mosaic virus. Nucleic Acids Res. 1986, 14, 623–633.
8. Dannull, J.; Surovoy, A.; Jung, G.; Moelling, K. Specific binding of HIV-1 nucleocapsid protein
to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues.
EMBO J. 1994, 13, 1525–1533.
9. Clever, J.; Sassetti, C.; Parslow, T.G. RNA secondary structure and binding sites for gag gene
products in the 5' packaging signal of human immunodeficiency virus type 1. J. Virol. 1995, 69,
10. Zhang, Y.; Barklis, E. Nucleocapsid protein effects on the specificity of retrovirus RNA
encapsidation. J. Virol. 1995, 69, 5716–5722.
11. Druillennec, S.; Caneparo, A.; de Rocquigny, H.; Roques, B.P. Evidence of interactions between
the nucleocapsid protein NCp7 and the reverse transcriptase of HIV-1. J. Biol. Chem. 1999, 274,
12. Cimarelli, A.; Sandin, S.; Hoglund, S.; Luban, J. Basic residues in human immunodeficiency virus
type 1 nucleocapsid promote virion assembly via interaction with RNA. J. Virol. 2000, 74,
13. Zhang, J.; Crumpacker, C.S. Human immunodeficiency virus type 1 nucleocapsid protein nuclear
localization mediates early viral mRNA expression. J. Virol. 2002, 76, 10444–10454.
14. Gottlinger, H.G.; Sodroski, J.G.; Haseltine, W.A. Role of capsid precursor processing and
myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc.
Natl. Acad. Sci. USA 1989, 86, 5781–5785.
15. Ciechanover, A.; Orian, A.; Schwartz, A.L. Ubiquitin-mediated proteolysis: Biological regulation
via destruction. Bioessays 2000, 22, 442–451.
16. Bres, V.; Kiernan, R.E.; Linares, L.K.; Chable-Bessia, C.; Plechakova, O.; Treand, C.; Emiliani, S.;
Peloponese, J.M.; Jeang, K.T.; Coux, O.; et al. A non-proteolytic role for ubiquitin in Tat-mediated
transactivation of the HIV-1 promoter. Nat. Cell Biol. 2003, 5, 754–761.
Viruses 2013, 5
17. Gargano, B.; Fiorillo, M.; Amente, S.; Majello, B.; Lania, L. p14ARF is capable of promoting
HIV-1 tat degradation. Cell Cycle 2008, 7, 1433–1439.
18. Orlowski, M.; Wilk, S. Ubiquitin-independent proteolytic functions of the proteasome. Arch.
Biochem. Biophys. 2003, 415, 1–5.
19. Asher, G.; Lotem, J.; Sachs, L.; Kahana, C.; Shaul, Y. Mdm-2 and ubiquitin-independent p53
proteasomal degradation regulated by NQO1. Proc. Natl. Acad. Sci. USA 2002, 99, 13125–13130.
20. Kim, J.H.; Sohn, S.Y.; Yen, T.S.; Ahn, B.Y. Ubiquitin-dependent and -independent proteasomal
degradation of hepatitis B virus X protein. Biochem. Biophys. Res. Commun. 2008, 366, 1036–1042.
21. Kim, J.H.; Kang, S.; Kim, J.; Ahn, B.Y. Hepatitis B virus core protein stimulates the proteasome-
mediated degradation of viral X protein. J. Virol. 2003, 77, 7166–7173.
22. Kingsman, SM.; Kingsman, KA. The regulation of human immunodeficiency virus type-1 gene
expression. Eur. J. Biochem. 1996, 240, 491–507.
23. Mann, D.A.; Mikaelian, I.; Zemmel, R.W.; Green, S.M.; Lowe, A.D.; Kimura, T.; Singh, M.;
Butler, P.J.; Gait, M.J.; Karn, J. A molecular rheostat: Co-operative rev binding to stem I of the
Rev-response element modulates human immunodeficiency virus type-1 late gene expression.
J. Mol. Biol. 1994, 241, 193–207.
24. Kaplan, A.H.; Swanstrom, R. Human immunodeficiency virus type 1 Gag proteins are processed
in two cellular compartments. Proc. Natl. Acad. Sci. USA 1991, 88, 4528–4532.
25. Burstein, H.; Bizub, D.; Skalka, A.M. Assembly and processing of avian retroviral Gag
polyproteins containing linked protease dimers. J. Virol. 1991, 65, 6165–6172.
© 2013 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article
distributed under the terms and conditions of the Creative Commons Attribution license